Literature DB >> 27726356

Design and Discovery of Functionally Selective Serotonin 2C (5-HT2C) Receptor Agonists.

Jianjun Cheng1, John D McCorvy, Patrick M Giguere, Hu Zhu, Terry Kenakin, Bryan L Roth, Alan P Kozikowski1.   

Abstract

On the basis of the structural similarity of our previous 5-HT2C agonists with the melatonin receptor agonist tasimelteon and the putative biological cross-talk between serotonergic and melatonergic systems, a series of new (2,3-dihydro)benzofuran-based compounds were designed and synthesized. The compounds were evaluated for their selectivity toward 5-HT2A, 5-HT2B, and 5-HT2C receptors in the calcium flux assay with the ultimate goal to generate selective 5-HT2C agonists. Selected compounds were studied for their functional selectivity by comparing their transduction efficiency at the G protein signaling pathway versus β-arrestin recruitment. The most functionally selective compound (+)-7e produced weak β-arrestin recruitment and also demonstrated less receptor desensitization compared to serotonin in both calcium flux and phosphoinositide (PI) hydrolysis assays. We report for the first time that selective 5-HT2C agonists possessing weak β-arrestin recruitment can produce distinct receptor desensitization properties.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27726356     DOI: 10.1021/acs.jmedchem.6b01194

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  6 in total

1.  Design of fluorinated cyclopropane derivatives of 2-phenylcyclopropylmethylamine leading to identification of a selective serotonin 2C (5-HT2C) receptor agonist without 5-HT2B agonism.

Authors:  Guiping Zhang; John D McCorvy; Sida Shen; Jianjun Cheng; Bryan L Roth; Alan P Kozikowski
Journal:  Eur J Med Chem       Date:  2019-08-14       Impact factor: 6.514

2.  5-HT2C Receptor Structures Reveal the Structural Basis of GPCR Polypharmacology.

Authors:  Yao Peng; John D McCorvy; Kasper Harpsøe; Katherine Lansu; Shuguang Yuan; Petr Popov; Lu Qu; Mengchen Pu; Tao Che; Louise F Nikolajsen; Xi-Ping Huang; Yiran Wu; Ling Shen; Walden E Bjørn-Yoshimoto; Kang Ding; Daniel Wacker; Gye Won Han; Jianjun Cheng; Vsevolod Katritch; Anders A Jensen; Michael A Hanson; Suwen Zhao; David E Gloriam; Bryan L Roth; Raymond C Stevens; Zhi-Jie Liu
Journal:  Cell       Date:  2018-02-01       Impact factor: 41.582

3.  Designing Functionally Selective Noncatechol Dopamine D1 Receptor Agonists with Potent In Vivo Antiparkinsonian Activity.

Authors:  Michael L Martini; Caroline Ray; Xufen Yu; Jing Liu; Vladimir M Pogorelov; William C Wetsel; Xi-Ping Huang; John D McCorvy; Marc G Caron; Jian Jin
Journal:  ACS Chem Neurosci       Date:  2019-08-20       Impact factor: 4.418

4.  Identification of natural products as novel ligands for the human 5-HT2C receptor.

Authors:  Yao Peng; Simeng Zhao; Yiran Wu; Haijie Cao; Yueming Xu; Xiaoyan Liu; Wenqing Shui; Jianjun Cheng; Suwen Zhao; Ling Shen; Jun Ma; Ronald J Quinn; Raymond C Stevens; Guisheng Zhong; Zhi-Jie Liu
Journal:  Biophys Rep       Date:  2018-03-09

5.  A Novel G Protein-Biased and Subtype-Selective Agonist for a G Protein-Coupled Receptor Discovered from Screening Herbal Extracts.

Authors:  Bingjie Zhang; Simeng Zhao; Dehua Yang; Yiran Wu; Ye Xin; Haijie Cao; Xi-Ping Huang; Xiaoqing Cai; Wen Sun; Na Ye; Yueming Xu; Yao Peng; Suwen Zhao; Zhi-Jie Liu; Guisheng Zhong; Ming-Wei Wang; Wenqing Shui
Journal:  ACS Cent Sci       Date:  2020-01-23       Impact factor: 14.553

Review 6.  The Impact of the Secondary Binding Pocket on the Pharmacology of Class A GPCRs.

Authors:  Attila Egyed; Dóra Judit Kiss; György M Keserű
Journal:  Front Pharmacol       Date:  2022-03-09       Impact factor: 5.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.